1. Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94143, United States
2. Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada
3. Graduate Program in Biophysics, University of California San Francisco, San Francisco, California 94143, United States
4. Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
5. Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada
6. Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California 94158, United States
7. Gladstone Institutes, San Francisco, California 94158, United States
8. Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
9. Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
10. Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
11. Enamine Ltd, Kyïv 02094, Ukraine
12. Institute of Bioorganic Chemistry and Petrochemistry, National Ukrainian Academy of Science, Kyïv 02660, Ukraine
13. National Taras Shevchenko University of Kyïv, Kyïv 01601, Ukraine
14. Chemspace, Riga LV-1082, Latvia
15. QBI COVID-19 Research Group (QCRG), San Francisco, California 94158, United States
16. Department of Medicine, University of California, San Francisco, San Francisco, California 94158, United States
17. Chan Zuckerberg Biohub, San Francisco, California 94158, United States
18. Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
19. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States